Skandinaviska Enskilda Banken (SEB)’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,000
Closed -$307K 1098
2021
Q2
$307K Buy
3,000
+2,500
+500% +$251K ﹤0.01% 924
2021
Q1
$49K Sell
500
-16,500
-97% -$1.5M ﹤0.01% 1074
2020
Q4
$1.31M Sell
17,000
-23,200
-58% -$1.79M 0.01% 758
2020
Q3
$2.96M Hold
40,200
0.02% 454
2020
Q2
$2.95M Hold
40,200
0.02% 458
2020
Q1
$2.32M Hold
40,200
0.02% 444
2019
Q4
$3.16M Buy
+40,200
New +$2.96M 0.02% 445

Other funds holding USNA

Skandinaviska Enskilda Banken (SEB)'s USNA Position: Q3 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 3,000 shares — an estimated $307K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in USNA in Q4 2019 and held it in 7 quarters. The position peaked at $3.16M in Q4 2019. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 3,000 Usana Health Sciences shares in Q3 2021, an estimated $307K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Usana Health Sciences in Q4 2019 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Usana Health Sciences position peaked at $3.16M in Q4 2019.
  • 180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2021, filed 10 Nov 2021.